Rare diseases
Investigational molecules
Locations
Back to France658 clinical trials in Grenoble, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Mavacamten for Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
FranceStudy of SYM024, SYM023, and SYM025 in Adults with Advanced Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Expression
FranceStudy of INCB099280 for Patients With Advanced Cutaneous Squamous Cell Carcinoma Not Suitable for Surgery or Radiotherapy
FranceStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
FranceStudy on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
FranceStudy on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia
FranceStudy on the Effectiveness of Paclitaxel, Carboplatin, and Durvalumab for Patients with Extensive Stage Small Cell Lung Cancer
FranceStudy on Spironolactone for Patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD)
FranceStudy of Rituximab compared to placebo in patients with anti-MAG neuropathy who are likely to respond well to treatment
FranceA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on head and neck cancers, multiple myeloma, and various types of leukemia. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.
Innovative approaches combining immunotherapy with standard treatments are showing promise in treating various forms of cancer.
Clinical investigations examining kidney transplant outcomes and rejection prevention. Research focuses on new therapeutic approaches for managing transplant-related complications.
Studies aim to improve transplant success rates and reduce rejection incidents through innovative medication protocols.
Research into narcolepsy and multiple sclerosis treatments, evaluating new therapeutic approaches for better symptom management and disease control.
Cutting-edge treatments being developed to address both rare and common neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
